Research and development

Oasmia focuses its research and development on enhancing the position of its proprietary XR-17 platform, including evaluating new active pharmaceutical ingredients. This screening targets effective products with low solubility in water, where the platform can have the most substantial impact. In addition, R&D also spearheads the technology transfer between Oasmia and its production partners as well as patent extension.